Search by Drug Name or NDC
NDC 69618-0065-01 Sennosides and Docusate Sodium 50; 8.6 mg/1; mg/1 Details
Sennosides and Docusate Sodium 50; 8.6 mg/1; mg/1
Sennosides and Docusate Sodium is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Reliable-1 Laboratories LLC. The primary component is DOCUSATE SODIUM; SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 69618-0065-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
Related Packages: 69618-0065-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Stool Softeners
Product Information
| NDC | 69618-0065 |
|---|---|
| Product ID | 69618-065_0424f184-bd82-fc4d-e063-6394a90aa923 |
| Associated GPIs | 46991002770320 |
| GCN Sequence Number | 048044 |
| GCN Sequence Number Description | sennosides/docusate sodium TABLET 8.6MG-50MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 13483 |
| HICL Sequence Number | 021772 |
| HICL Sequence Number Description | SENNOSIDES/DOCUSATE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Sennosides and Docusate Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides, Docusate Sodium |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50; 8.6 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Labeler Name | Reliable-1 Laboratories LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69618-0065-01 (69618006501)
| NDC Package Code | 69618-065-01 |
|---|---|
| Billing NDC | 69618006501 |
| Package | 100 TABLET in 1 BOTTLE (69618-065-01) |
| Marketing Start Date | 2020-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |